Search

everythinglearnresearchcommunity

for

Search:↓

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Using existing drugs for new treatments is cost-effective and safer.

Certain drugs may cause vitiligo, so patients should be monitored.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

No cure exists for alopecia areata, and treatments are personalized.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Leflunomide and anthralin may effectively treat severe alopecia areata.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

New methods are being developed to improve drug delivery to the brain.

Ascorbic acid derivatives improve drug delivery systems.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Balancing testosterone may reduce COVID-19 severity.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Signaling pathways are key targets for developing effective drugs.

Fasting may reduce chemotherapy side effects.

Tribulus terrestris may protect the liver from drug damage.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Certain genes can predict how well breast cancer patients respond to chemotherapy.